Rationally Engineered Bispecific Nanoimmunoblocker Restores Anticancer Immunity via Dual Immune Checkpoint Blockade
ACS Nano · 2025
DOI: 10.1021/acsnano.4c13463 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Peixin Guan und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, 163 Xianlin Avenue, …. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Antibodies, Bispecific. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Nanjing University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, 163 Xianlin Avenue, Nanjing 210023, China.
ORCID-Profile: Zhen Liu
Förderung
- Nanjing University
- National Natural Science Foundation of China
Zitieren
APA
Guan, P., Jin, F., Zhang, A., Gao, S., & Liu, Z. (2025). Rationally Engineered Bispecific Nanoimmunoblocker Restores Anticancer Immunity via Dual Immune Checkpoint Blockade. ACS Nano. https://doi.org/10.1021/acsnano.4c13463
Vancouver
Guan P, Jin F, Zhang A, Gao S, Liu Z. Rationally Engineered Bispecific Nanoimmunoblocker Restores Anticancer Immunity via Dual Immune Checkpoint Blockade. ACS Nano. 2025. doi:10.1021/acsnano.4c13463
BibTeX
@article{Guan2025,
author = {Guan, Peixin and Jin, Fang and Zhang, Anqi and Gao, Song and Liu, Zhen},
title = {Rationally Engineered Bispecific Nanoimmunoblocker Restores Anticancer Immunity via Dual Immune Checkpoint Blockade},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.4c13463}
}
EUVIMED